1-methyl-1,2,3,4-tetrahydroisoquinoline has been researched along with olanzapine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antkiewicz-Michaluk, L; Białoń, M; Wąsik, A; Żarnowska, M | 1 |
| Antkiewicz-Michaluk, L; Białoń, M; Chocyk, A; Majcher-Maślanka, I; Michalski, K; Wąsik, A; Żarnowska, M | 1 |
2 other study(ies) available for 1-methyl-1,2,3,4-tetrahydroisoquinoline and olanzapine
| Article | Year |
|---|---|
Comparison of the effects of 1MeTIQ and olanzapine on performance in the elevated plus maze test and monoamine metabolism in the brain after ketamine treatment.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Anxiety; Behavior, Animal; Brain; Dopamine; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Ketamine; Locomotion; Male; Maze Learning; Monoamine Oxidase Inhibitors; Norepinephrine; Olanzapine; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Serotonin; Tetrahydroisoquinolines | 2019 |
1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Fear; Male; Olanzapine; Rats; Rats, Sprague-Dawley; Schizophrenia; Social Interaction; Tetrahydroisoquinolines | 2021 |